Survival Gains from First‐Line Systemic Therapy in Metastatic Non‐Small Cell Lung Cancer in the U.S., 1990–2015: Progress and Opportunities

BACKGROUND. Approximately 190,000 Americans are diagnosed with non‐small cell lung cancer (NSCLC) annually, and about half have metastatic (Stage IV) disease. These patients have historically had poor survival prognosis, but several new therapies introduced since 2000 provide options for improved ou...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncologist
Hauptverfasser: Roth, Joshua A., Goulart, Bernardo H. L., Ravelo, Arliene, Kolkey, Holli, Ramsey, Scott D.
Format: Artigo
Sprache:Inglês
Veröffentlicht: AlphaMed Press 2017
Schlagworte:
Health Outcomes and Economic of Cancer Care
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5344635/
https://ncbi.nlm.nih.gov/pubmed/28242792
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2016-0253
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge